The JSE edged lower on Thursday, taking a breather after reaching a series of peaks over the past few days, during which the all share added about 4%. On Thursday, investors appeared ready to begin lightening their exposure to a few counters which had enjoyed a decent run in the past eight trading days. The loss of momentum was also partly attributable to a continuing recovery in the rand holding back big dual-listed shares, which invariably set the direction for the market. Soon after midday, the rand bought a single dollar for R13.50, from R13.86 at the start of the week, with the stronger currency proving favourable to certain segments of the market, including banks and retailers. The all share was down 0.20% to 57,654.80 points at lunchtime, while the top 40 lost 0.31%. Aspen Pharmacare was the best performer among the blue-chip companies, while the recently sold-down shares in the mid-and small-cap categories continued to recover. Global markets chugged along at a steady pace o...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.